Combinations of a pyrimidine containing NNRTI with RT inhibitors

Details for Australian Patent Application No. 2004268390 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Stoffels, Paul

Agent Shelston IP

Pub. Number AU-B-2004268390

PCT Pub. Number WO2005/021001

Priority 03103319.4 08.09.03 EP; 03103275.8 03.09.03 EP; 60/499,771 03.09.03 US; 60/508,486 03.10.03 US; 03103668.4 02.10.03 EP; 03103335.0 10.09.03 EP

Filing date 3 September 2004

Wipo publication date 10 March 2005

Acceptance publication date 31 March 2011

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/52 (2006.01)

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/021001 Priority application(s): WO2005/021001

7 September 2006 Amendment Made

  The nature of the amendment is: Amend the inventor name from Stoffels, Paul? to Stoffels, Paul

7 September 2006 Change of Name(s) of Applicant(s), Section 104

  Tibotec Pharmaceuticals Ltd.? The name of the applicant has been changed to Tibotec Pharmaceuticals Ltd.

31 March 2011 Application Accepted

  Published as AU-B-2004268390

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268394-Method and apparatus for reducing the detrimental effects of a fire

2004268388-Use of 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity